BTIG on Edwards Lifesciences (EW): 'Right on Time: TAVR National Coverage Analysis Opened for Review'
Tweet Send to a Friend
BTIG analyst Marie Thibault reiterated a Buy rating and $103.00 price target on Edwards Lifesciences (NYSE: EW)The analyst comments "This ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
